Model of neonatal meningitis caused by Escherichia coli K1 in guinea pigs

The Journal of Infectious Diseases
R E SinaiC H Pai

Abstract

A total of 88 neonatal guinea pigs was inoculated intranasally with a clinical isolate of Escherichia coli K1 that had been passaged once in the peritoneum of an adult guinea pig; 74 animals became bacteremic, of which 54 had meningitis, 12 hr after inoculation. Bacteremia and/or meningitis occurred consistently in repeated experiments. It was possible to obtain serial specimens of cerebrospinal fluid by cisternal puncture without killing the animals. The induction of meningitis in a predictable fashion without disrupting the blood-brain barrier and the ability to study the cerebrospinal fluid without killing the animal make this a useful model of human neonatal meningitis caused by E. coli K1.

Citations

Mar 14, 2007·Microbes and Infection·José Maria MaiquesPedro F Viladrich
Jul 3, 2019·Frontiers in Microbiology·Brandon J KimKelly S Doran

Related Concepts

Aminoglycosides
Metazoa
Blood - Brain Barrier Anatomy
Brain
Escherichia Coli Infections
Cavia porcellus
Pachymeningitis

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.